At a Glance -
MFN Pricing Returns: The EO revives effort to link U.S. drug prices to those in peer countries, calling for voluntary industry action.
Aggressive Action on the Table: If progress on voluntary price cuts...more
5/22/2025
/ Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Most-Favored Nations ,
Pharmaceutical Industry ,
Popular ,
Proposed Rules ,
Regulatory Reform ,
Trump Administration
As discussed in our May 6, 2024, Client Alert, earlier this year FDA issued its Final Rule for the regulation of laboratory-developed tests (LDTs) that the FDA has historically treated with enforcement discretion. A week...more